The various LOX family members have been identified as important players in stromal remodeling at the primary tumour which facilitates cancer progression in numerous cancer types, as summarized in Table 1, and therefore, these enzymes have potential as anti-stromal targets. The gene discussed is LOX; the disease is neoplasm.